Contact Genevieve

Speaking Engagements

  

Welcome to the Optimizing AAV Safety Summit: Predict & Monitor AAV Safety Signals to De-Risk Genetic Therapy Development Hundreds of clinical trials using AAV are underway, with several hundred more in preclinical development.

06-08 September 2022
  

Developing safe and effective gene therapies using AAV vectors is hindered by challenges related to the immune response. However, over the past two decades, drug developers have identified and are working on solutions to various immune responses to AAV vectors.

The 4th Annual Gene Therapy Immunogenicity Summit is an opportunity for gene ther

05-07 September 2023